A Pilot Mixed-Methods Study to Establish the Clinical Usefulness of a Chronic Pain Profile (CPP) for Pain Management.
clinical research
pain
pain management
qualitative research
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
18 Aug 2023
18 Aug 2023
Historique:
received:
05
07
2023
revised:
14
08
2023
accepted:
17
08
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
The Chronic Pain Profile (CPP) was developed as a tool for patients to document types and levels of use for all pain management strategies used. This pilot mixed-methods (quantitative and qualitative methods) study aimed to assess the perceived clinical usefulness of the CPP and identify potential areas of difficulty using the CPP among a sample of pharmacists. Data were obtained from an online survey of pharmacists licensed to practice in Arizona. Quantitative analysis included assessing the clinical usefulness of the CPP using 10 numerical items (scores ≥50% = useful), 5 ordinal items (scores ≥ 4 out of 5 = useful), and 11 open-response items. Qualitative analysis was conducted by two independent researchers who coded the comments and identified key themes through consensus. Data were collected for 33 individuals. Mean usefulness scores ranged from 66.6 ± 22.4 to 80.9 ± 23.5, and three of the five ordinal items had a median score ≥ 4. Three key themes (and subthemes) were identified: favorable features of the CPP, which included promoting patient advocacy and saving time when accessing pain information; using the CPP, which included evaluating of the effectiveness and appropriateness of the pain management approach and identifying gaps in patient knowledge; and limitations of the CPP, which included absence of customization, interpretation issues, complexity and wording issues, and concerns of internal consistency and reliability. This pilot study provides initial evidence of the CPP's clinical usefulness that could ultimately be used to help manage pain and improve health outcomes. Further analyses are needed to assess the CPP's validity and explore its use in wider populations of patients with pain.
Identifiants
pubmed: 37629416
pii: jcm12165374
doi: 10.3390/jcm12165374
pmc: PMC10455169
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : American Association of Colleges of Pharmacy
ID : 0
Références
Emerg Med Int. 2015;2015:490947
pubmed: 26421190
J Neurosci Res. 2022 Jan;100(1):10-18
pubmed: 32770580
MMWR Morb Mortal Wkly Rep. 2023 Apr 14;72(15):379-385
pubmed: 37053114
Can J Hosp Pharm. 2012 Sep;65(5):360-7
pubmed: 23129864
Pain. 2022 Feb 1;163(2):e328-e332
pubmed: 33990113
Scand J Pain. 2019 Jan 28;19(1):9-23
pubmed: 30375350
Pain. 2020 Sep 1;161(9):1976-1982
pubmed: 32694387
Psychol Res Behav Manag. 2014 Apr 10;7:115-24
pubmed: 24748826
Pain Med. 2019 Jul 1;20(7):1281-1293
pubmed: 30204920
MMWR Morb Mortal Wkly Rep. 2018 Sep 14;67(36):1001-1006
pubmed: 30212442
PLoS One. 2015 Oct 06;10(10):e0139577
pubmed: 26440647
J Pain. 2015 Aug;16(8):769-80
pubmed: 26028573
BMJ Open. 2016 Feb 23;6(2):e010003
pubmed: 26908524
JAMA Intern Med. 2016 Mar;176(3):338-9
pubmed: 26902856
Cochrane Database Syst Rev. 2017 Apr 24;4:CD011279
pubmed: 28436583
BMC Musculoskelet Disord. 2015 Oct 09;16:288
pubmed: 26453452
Pain Res Manag. 2018 Dec 12;2018:2530286
pubmed: 30651900
JAMA. 2018 Apr 17;319(15):1535-1537
pubmed: 29590287
Med Care. 2008 Nov;46(11):1157-62
pubmed: 18953226
J Pain. 2012 Aug;13(8):715-24
pubmed: 22607834